NCT03281811View on ClinicalTrials.gov

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

February 25, 2020

Study Completion Date

August 12, 2020

Conditions

Refractory Mycosis Fungoides

Interventions

DRUG

Aminolevulinic Acid Hydrochloride

Given topically

DRUG

Photodynamic Therapy

Undergo PDT

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Radiation Therapy

Undergo RT

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER